ValiRx to collaborate on gene silencing tech
Under the agreement, Pharmatest will design GeneICE constructs and test them in cancer model systems.
Company
ValiRx PLC
LON:VAL
ValiRx is a drug development company, which focuses on the translation of scientific innovation into clinical candidates for cancer, related conditions and women’s health. The company's specialised business model connects science, finance and commerce to accelerate early-stage drug development. It identifies proprietary and novel drug candidates with the potential to improve patient lives, providing the expertise and investment required for optimised development and value creation.
310 stories · page 15 of 16
Investments and investor services
Proactive news highlights including AFC Energy, ValiRx, ITM Power, Ebiquity, Amur Minerals...
Shares in Atlantic Coal flew higher today but Ortac Resources took the top spot on the risers board.
ValiRx extends lymphoma biomarker patent protection to Japan
ValiRx said the biomarkers separate types of B-cell lymphomas into different prognostic groups.
ValiRx well placed to keep growth going
Its lead compound, VAL201, has passed safety controls and is showing early indications of efficacy even at low dosage.
ValiRx arranges £2.45mln finance for development work
The proceeds will help fund the drug developer’s therapeutic, biomarker and intellectual property developments.
Risers & Fallers: SABMiller, Styles & Wood, Dillistone, Cello Group, Synairgen and Quadrise Fuels
Below are the main news-driven share price movements at 12.30pm.
Investments and investor services
Most followed: Aviva, RSA Insurance, Shell, Sound Oil, Super Thursday, ValiRx, Zurich Insurance
Bank of England governor Mark Carney hopes the adoption of Three-In-One will oil the decision making process.
ValiRx signs collaboration deal with Leeds University
Professor Taylor has recently moved to the University of Leeds where helped develop VAL401, one of ValiRx's lead products.
Archive
FTSE100 heads lower as market runs out of positives
Britain's top share index closed almost 20 points lower...
Archive
Proactive news summary, including ValiRx, Mwana Africa, Versarien and Clinigen
Pharma and biotech stocks were prominent and ValiRx shares were boosted....
Investments and investor services
Risers & Fallers: blur Group, Arbuthnot, Admiral Group, Cable & Wireless, Atlas and more
blur Group attracted 30% more large business customers to its e-commerce platforms while Cable & Wireless reported flat first quarter mobile revenue.
ValiRx to up dosage in prostate cancer trial
"We are now nearing dose levels that we originally projected would be therapeutically significant.”
Archive
Proactive news summary, including Jubilee Platinum, Metal Tiger, Lydian International, Sound Oil and Strategic Minerals
Shares in Jubilee Platinum soared today on disposal news....
UPDATE - ValiRx to start clinical trial of lung cancer drug
The drug is being developed through a joint venture with Tangent Profiling.